Related Experiment Video

Updated: Jun 4, 2025

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.4K

MIRO2 promotes cancer invasion and metastasis via MYO9B suppression of RhoA activity

Dillon P Boulton1, Connor J Hughes1, Valentina Vaira2

  • 1Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA; Pharmacology Graduate Program, University of Colorado, Aurora, CO 80045, USA.

Cell Reports
|December 26, 2024
PubMed

Insights

Mitochondrial Rho GTPase 2 (MIRO2) drives cancer cell invasion and metastasis. Targeting MIRO2 and its partner MYO9B may offer new therapeutic strategies for advanced cancers.

Area of Science:

  • Cancer Biology
  • Cellular Metastasis
  • Molecular Oncology

Background:

  • Metastasis to vital organs is a primary cause of cancer mortality.
  • Mitochondrial Rho GTPase 2 (MIRO2) has been implicated in prostate cancer growth.
  • The role of MIRO2 in the broader metastatic cascade remains unexplored.

Purpose of the Study:

  • To investigate the role of MIRO2 in cancer cell invasion and metastasis.
  • To elucidate the molecular mechanisms by which MIRO2 influences the metastatic cascade.

Main Methods:

  • Knockdown of MIRO2 in prostate and breast cancer cell lines.
  • In vitro invasion assays and in vivo metastasis mouse models.
  • Analysis of MIRO2's binding partner, unconventional myosin 9B (MYO9B), and RhoA activity.

Main Results:

  • MIRO2 depletion significantly reduced tumor cell invasion and metastatic burden in preclinical models.
  • Depletion of MYO9B mimicked MIRO2 depletion effects on invasion and increased active RhoA.
  • Dual ablation of MIRO2 and RhoA fully restored tumor cell invasion, indicating MIRO2's role in MYO9B-mediated invasion.

Conclusions:

  • MIRO2 promotes cancer cell invasion and metastasis through a pathway involving MYO9B and RhoA.
  • MIRO2 represents a potential therapeutic target for advanced-stage cancers.
  • Understanding the MIRO2-MYO9B-RhoA axis offers insights into controlling cancer spread.
Keywords:
CP: CancerCP: Molecular biologyMIRO2MYO9BRhoAmetastasissmall GTPasestumor cell invasion

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.4K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.5K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K